NCT07206641

Brief Summary

The aim of this study is to investigate the effect of inspiratory muscle strengthening exercises on bilateral parasternal intercostal muscle thickness and bilateral diaphragm muscle thickness in stroke patients and to present new data on whether the possible effect on the affected side can be associated with changes in respiratory parameters. Furthermore, as previous literature has shown that 4-week exercise programs are more effective than \>6-week exercise programs, an interim assessment is planned for the second week of treatment in this study to evaluate shorter-term changes. Four weeks after completion of the exercise program (in the 8th week), patients will be re-evaluated to track potential short-term effects.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
4mo left

Started Dec 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Dec 2025Dec 2026

First Submitted

Initial submission to the registry

September 4, 2025

Completed
29 days until next milestone

First Posted

Study publicly available on registry

October 3, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

November 18, 2025

Status Verified

September 1, 2025

Enrollment Period

1 year

First QC Date

September 4, 2025

Last Update Submit

November 16, 2025

Conditions

Keywords

StrokeIMTInspiratory Muscle TrainingDiapragm ThicknessIntercostal muscle thickness

Outcome Measures

Primary Outcomes (2)

  • Diaphragm muscle thickness

    In this study, ultrasonography will be used to examine the structure and function of the muscle and to measure muscle thickness at the end of inspiration and expiration.

    Will be performed using an ultrasound device before treatment, at the 2nd week of treatment, at the end of treatment (4th week), and 4 weeks after the completion of treatment (8th week).

  • Intercostal muscle thickness

    In this study, ultrasonography will be used to examine the structure and function of the muscle and to measure muscle thickness at the end of inspiration and expiration.

    Will be performed using an ultrasound device before treatment, at the 2nd week of treatment, at the end of treatment (4th week), and 4 weeks after the completion of treatment (8th week).

Secondary Outcomes (6)

  • Berg Balance Scale

    Will be evaluated before treatment, at the 2nd week of treatment, at the end of treatment (4th week), and 4 weeks after the completion of treatment (8th week).

  • Tinetti Test

    Will be evaluated before treatment, at the 2nd week of treatment, at the end of treatment (4th week), and 4 weeks after the completion of treatment (8th week).

  • Stroke-Specific Quality of Life Scale

    Will be evaluated before treatment, at the 2nd week of treatment, at the end of treatment (4th week), and 4 weeks after the completion of treatment (8th week).

  • Forced Vital Capacity

    Will be measured using spirometry before treatment, at the end of treatment (4th week), and 4 weeks after the completion of treatment (8th week)

  • Forced Expiratory Volume

    Will be measured using spirometry before treatment, at the end of treatment (4th week), and 4 weeks after the completion of treatment (8th week).

  • +1 more secondary outcomes

Study Arms (1)

GROUP 1: Patients diagnosed with stroke who will be followed with inspiratory strengthening exercise

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients aged 18-65 years diagnosed with stroke Sample Size of the Study: 35 Stroke patients

You may qualify if:

  • Patients with a history of ischemic or hemorrhagic stroke
  • Aged 18-65 years

You may not qualify if:

  • Presence of concomitant acute or chronic lung disease
  • History of thoracic or abdominal surgery
  • Presence of another neuromuscular disease
  • Patients with aphasia or impaired cognition
  • Severe heart disease
  • Active cancer
  • Mini-Mental State Examination (MMSE) score ≤ 24
  • Active smoking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara Üniversitesi Tıp Fakültesi, Istanbul, Maltepe 34854

Istanbul, Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Ozge Kenis Coskun

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2025

First Posted

October 3, 2025

Study Start

December 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

November 18, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations